Notify me when LANCE ALSTODT files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| BRTX | BioRestorative Therapies, Inc. | Common Stock | 15.5% | $2,189,152 | 1,236,809 | ALSTODT LANCE | 14 Feb 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|